Aquestive Therapeutics Stock Price on December 19, 2024
| AQST Stock | USD 3.53 0.13 3.55% |
Below is the normalized historical share price chart for Aquestive Therapeutics extending back to July 25, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Aquestive Therapeutics stands at 3.53, as last reported on the 27th of December, with the highest price reaching 3.53 and the lowest price hitting 3.53 during the day.
If you're considering investing in Aquestive Stock, it is important to understand the factors that can impact its price. Aquestive Therapeutics secures Sharpe Ratio (or Efficiency) of -0.1, which signifies that the company had a -0.1% return per unit of risk over the last 3 months. Aquestive Therapeutics exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Aquestive Therapeutics' Mean Deviation of 3.18, risk adjusted performance of (0.07), and Standard Deviation of 4.02 to double-check the risk estimate we provide.
Liabilities And Stockholders Equity is likely to gain to about 66.8 M in 2024, despite the fact that Total Stockholder Equity is likely to grow to (101.2 M). . At this time, Aquestive Therapeutics' Price To Sales Ratio is comparatively stable compared to the past year. Price Earnings To Growth Ratio is likely to gain to 0.18 in 2024, despite the fact that Price To Operating Cash Flows Ratio is likely to grow to (18.42). Aquestive Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 25th of July 2018 | 200 Day MA 4.0146 | 50 Day MA 4.6544 | Beta 2.816 |
Aquestive |
Sharpe Ratio = -0.1045
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | AQST |
Estimated Market Risk
| 3.99 actual daily | 35 65% of assets are more volatile |
Expected Return
| -0.42 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Aquestive Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aquestive Therapeutics by adding Aquestive Therapeutics to a well-diversified portfolio.
Enterprise Value Ebitda (1.81) | Price Sales 5.6657 | Shares Float 80.1 M | Wall Street Target Price 10.8333 | Earnings Share (0.45) |
Aquestive Therapeutics Main Headline on 19th of December 2024
Aquestive Therapeutics Receives U.S. FDA Orphan Drug Exclusi... by finance.yahoo.com
U.S. FDA Orphan Drug exclusivity provides seven years of market exclusivity for Libervant Buccal Film in the United States for the treatment of seizure clusters in patients ages 2 to 5WARREN, N.J., Dec. 19, 2024 -- Aquestive Therapeutics, Inc. , a pharmaceutical company advancing medicines to bring meaningful improvement to patients lives through innovative science and delivery technologies, today announced the U.S. Food
Aquestive Therapeutics Valuation on December 19, 2024
It is possible to determine the worth of Aquestive Therapeutics on a given historical date. On December 19, 2024 Aquestive was worth 3.62 at the beginning of the trading date compared to the closed value of 3.64. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Aquestive Therapeutics stock. Still, in general, we apply an absolute valuation method to find Aquestive Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Aquestive Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Aquestive Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 3.89 | 3.89 | 3.38 | 3.46 | 2,881,681 | |
12/19/2024 | 3.62 | 3.76 | 3.52 | 3.64 | 1,484,344 |
| 3.56 | 3.77 | 3.52 | 3.65 | 1,345,414 |
| Backtest Aquestive Therapeutics | | | Aquestive Therapeutics History | | | Aquestive Therapeutics Valuation | Previous | Next |
Aquestive Therapeutics Trading Date Momentum on December 19, 2024
| On December 20 2024 Aquestive Therapeutics was traded for 3.65 at the closing time. The top price for the day was 3.77 and the lowest listed price was 3.52 . The trading volume for the day was 1.3 M. The trading history from December 20, 2024 was a factor to the next trading day price appreciation. The overall trading delta against the next closing price was 0.27% . The overall trading delta against the current closing price is 0.55% . |
Aquestive Therapeutics Fundamentals Correlations and Trends
By evaluating Aquestive Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Aquestive Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Aquestive financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Aquestive Therapeutics Stock history
Aquestive Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Aquestive is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Aquestive Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Aquestive Therapeutics stock prices may prove useful in developing a viable investing in Aquestive Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 61.3 M | 37.4 M | |
| Net Loss | -49 M | -51.4 M |
Aquestive Therapeutics Quarterly Net Working Capital |
|
Aquestive Therapeutics Stock Technical Analysis
Aquestive Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Aquestive Therapeutics Period Price Range
Low | December 27, 2024
| High |
0.00 | 0.00 |
Aquestive Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Aquestive Therapeutics December 27, 2024 Market Strength
Market strength indicators help investors to evaluate how Aquestive Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aquestive Therapeutics shares will generate the highest return on investment. By undertsting and applying Aquestive Therapeutics stock market strength indicators, traders can identify Aquestive Therapeutics entry and exit signals to maximize returns
Aquestive Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Aquestive Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Aquestive Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Aquestive to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.36) | |||
| Total Risk Alpha | (0.63) | |||
| Treynor Ratio | 0.3638 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Aquestive Stock Analysis
When running Aquestive Therapeutics' price analysis, check to measure Aquestive Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aquestive Therapeutics is operating at the current time. Most of Aquestive Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aquestive Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aquestive Therapeutics' price. Additionally, you may evaluate how the addition of Aquestive Therapeutics to your portfolios can decrease your overall portfolio volatility.